Inventor
MUELLNER STEFAN
DE34 patents
⚠️ This page may combine multiple inventors who share the name “MUELLNER STEFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOECHST AG
26 patentsUS5430110AJul 4, 1995
Polyvinylamine derivatives having hydrophilic centers, processes for their preparation and the use of the compounds as a medicament, active compound carrier and foodstuff auxiliary
HOECHST AG122 citations96
US5428112AJun 27, 1995
Crosslinked, nitrogen-containing vinyl copolymers, processes for their preparation and the use of these compounds
HOECHST AG67 citations96
US5250524AOct 5, 1993
Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
HOECHST AG69 citations94
US5624903AApr 29, 1997
Phosphoinositol-glycan-peptide with insulin-like action
HOECHST AG30 citations92
US5430116AJul 4, 1995
Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals
HOECHST AG45 citations92
US5976811ANov 2, 1999
Antibodies for the selective immunological determination of bile acids in biological matrices
HOECHST AG46 citations91
US5780592AJul 14, 1998
Compositions comprising lipoproteins and crotonamide derivatives
HOECHST AG59 citations91
US5750679AMay 12, 1998
Process for obtaining pharmacologically active compounds from complex mixtures of substances
HOECHST AG30 citations91
US6337325B1Jan 8, 2002
Combined preparation for the therapy of immune diseases
HOECHST AG35 citations89
US5990103ANov 23, 1999
Combination preparation for use in immunological diseases
HOECHST AG27 citations89
US4948481AAug 14, 1990
Process and device for the electrophoretic separation, purification and concentration of charged or polarizable macromolecules
HOECHST AG21 citations82
US5622934AApr 22, 1997
Peptides with an insulin-like action
HOECHST AG11 citations74
US5268272ADec 7, 1993
Complexes containing glycosyl-phosphatidylinositol proteins and cholanic acid derivatives, a process for their preparation and their use
HOECHST AG18 citations74
US6121479ASep 19, 2000
Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
HOECHST AG7 citations73
US5977151ANov 2, 1999
Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
HOECHST AG9 citations73
US5401498AMar 28, 1995
Pharmaceuticals comprising polyhydroxymethylene derivatives, process for their preparation and use
HOECHST AG19 citations73
US5728686AMar 17, 1998
Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals
HOECHST AG15 citations72
US6011051AJan 4, 2000
Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
HOECHST AG7 citations71
US5981536ANov 9, 1999
Use of xanthine derivatives for the modulation of apoptosis
HOECHST AG12 citations71
US5627173AMay 6, 1997
Phosphonoacetic acid derivatives and their use for treating degenerative joint disorders
HOECHST AG13 citations71
US5714138AFeb 3, 1998
Polyaspartamide derivatives as adsorbents for bile acids, polyaspartamide derivatives loaded with bile acids and process for their preparation and their use as pharmaceuticals
HOECHST AG3 citations63
US5559258ASep 24, 1996
Ethylenically unsaturated bile acid derivatives, processes for their preparation and precursors
HOECHST AG3 citations63
US5514599AMay 7, 1996
Antibodies against highly conserved amino acid sequences of insulin a process for the preparation of these antibodies and the use thereof in immunoassays
HOECHST AG5 citations63
US5461035AOct 24, 1995
Short peptides with insulin activity
HOECHST AG4 citations63
US5856330AJan 5, 1999
Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
HOECHST AG5 citations60
US5631326AMay 20, 1997
Crosslinked nitrogen-containing vinyl copolymers processes for their preparation and the use of these compounds
HOECHST AG1 citations52
AVENTIS RES & TECH GMBH & CO
5 patentsUS6589785B1Jul 8, 2003
Disrupting cells and/or tissue in solid state in presence of solid denaturing substance
AVENTIS RES & TECH GMBH & CO11 citations74
US5942429AAug 24, 1999
DEAH-box proteins
AVENTIS RES & TECH GMBH & CO2 citations61
US6403299B1Jun 11, 2002
DEAH-box proteins
AVENTIS RES & TECH GMBH & CO0 citations51
US6251645B1Jun 26, 2001
DEAH-box proteins
AVENTIS RES & TECH GMBH & CO0 citations51
US6582691B1Jun 24, 2003
Expression vector for the production of dead proteins
AVENTIS RES & TECH GMBH & CO0 citations42